164 related articles for article (PubMed ID: 33517393)
1. Mosaic IL6ST variant inducing constitutive GP130 cytokine receptor signaling as a cause of neonatal onset immunodeficiency with autoinflammation and dysmorphy.
Materna-Kiryluk A; Pollak A; Gawalski K; Szczawinska-Poplonyk A; Rydzynska Z; Sosnowska A; Cukrowska B; Gasperowicz P; Konopka E; Pietrucha B; Grzywa TM; Banaszak-Ziemska M; Niedziela M; Skalska-Sadowska J; Stawiński P; Śladowski D; Nowis D; Ploski R
Hum Mol Genet; 2021 Apr; 30(3-4):226-233. PubMed ID: 33517393
[TBL] [Abstract][Full Text] [Related]
2. The Human GP130 Cytokine Receptor and Its Expression-an Atlas and Functional Taxonomy of Genetic Variants.
Chen YH; van Zon S; Adams A; Schmidt-Arras D; Laurence ADJ; Uhlig HH
J Clin Immunol; 2023 Dec; 44(1):30. PubMed ID: 38133879
[TBL] [Abstract][Full Text] [Related]
3. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
Chen J; Zhang Y; Petrus MN; Xiao W; Nicolae A; Raffeld M; Pittaluga S; Bamford RN; Nakagawa M; Ouyang ST; Epstein AL; Kadin ME; Del Mistro A; Woessner R; Jaffe ES; Waldmann TA
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3975-3980. PubMed ID: 28356514
[TBL] [Abstract][Full Text] [Related]
4. Functional and structural analysis of cytokine-selective IL6ST defects that cause recessive hyper-IgE syndrome.
Chen YH; Zastrow DB; Metcalfe RD; Gartner L; Krause F; Morton CJ; Marwaha S; Fresard L; Huang Y; Zhao C; McCormack C; Bick D; Worthey EA; Eng CM; Gold J; Undiagnosed Diseases Network ; Montgomery SB; Fisher PG; Ashley EA; Wheeler MT; Parker MW; Shanmugasundaram V; Putoczki TL; Schmidt-Arras D; Laurence A; Bernstein JA; Griffin MDW; Uhlig HH
J Allergy Clin Immunol; 2021 Aug; 148(2):585-598. PubMed ID: 33771552
[TBL] [Abstract][Full Text] [Related]
5. Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting.
Zanders L; Kny M; Hahn A; Schmidt S; Wundersitz S; Todiras M; Lahmann I; Bandyopadhyay A; Wollersheim T; Kaderali L; Luft FC; Birchmeier C; Weber-Carstens S; Fielitz J
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):713-727. PubMed ID: 34821076
[TBL] [Abstract][Full Text] [Related]
6. Mutations leading to constitutive active gp130/JAK1/STAT3 pathway.
Pilati C; Zucman-Rossi J
Cytokine Growth Factor Rev; 2015 Oct; 26(5):499-506. PubMed ID: 26188635
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma.
Poussin K; Pilati C; Couchy G; Calderaro J; Bioulac-Sage P; Bacq Y; Paradis V; Leteurtre E; Sturm N; Ramos J; Guettier C; Bardier-Dupas A; Boulai A; Wendum D; Selves J; Izard T; Nault JC; Zucman-Rossi J
Oncoimmunology; 2013 Dec; 2(12):e27090. PubMed ID: 24501689
[TBL] [Abstract][Full Text] [Related]
8. A biallelic mutation in
Schwerd T; Twigg SRF; Aschenbrenner D; Manrique S; Miller KA; Taylor IB; Capitani M; McGowan SJ; Sweeney E; Weber A; Chen L; Bowness P; Riordan A; Cant A; Freeman AF; Milner JD; Holland SM; Frede N; Müller M; Schmidt-Arras D; Grimbacher B; Wall SA; Jones EY; Wilkie AOM; Uhlig HH
J Exp Med; 2017 Sep; 214(9):2547-2562. PubMed ID: 28747427
[TBL] [Abstract][Full Text] [Related]
9. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours.
Rebouissou S; Amessou M; Couchy G; Poussin K; Imbeaud S; Pilati C; Izard T; Balabaud C; Bioulac-Sage P; Zucman-Rossi J
Nature; 2009 Jan; 457(7226):200-4. PubMed ID: 19020503
[TBL] [Abstract][Full Text] [Related]
10. New Dominant-Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130-Dependent Hyper-IgE Syndrome.
Arlabosse T; Materna M; Riccio O; Schnider C; Angelini F; Perreau M; Rochat I; Superti-Furga A; Campos-Xavier B; Héritier S; Pereira A; Deswarte C; Lévy R; Distefano M; Bustamante J; Roelens M; Borie R; Le Brun M; Crestani B; Casanova JL; Puel A; Hofer M; Fieschi C; Theodoropoulou K; Béziat V; Candotti F
J Clin Immunol; 2023 Oct; 43(7):1566-1580. PubMed ID: 37273120
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
[TBL] [Abstract][Full Text] [Related]
12. Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations.
Forbes LR; Vogel TP; Cooper MA; Castro-Wagner J; Schussler E; Weinacht KG; Plant AS; Su HC; Allenspach EJ; Slatter M; Abinun M; Lilic D; Cunningham-Rundles C; Eckstein O; Olbrich P; Guillerman RP; Patel NC; Demirdag YY; Zerbe C; Freeman AF; Holland SM; Szabolcs P; Gennery A; Torgerson TR; Milner JD; Leiding JW
J Allergy Clin Immunol; 2018 Nov; 142(5):1665-1669. PubMed ID: 30092289
[TBL] [Abstract][Full Text] [Related]
13. Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas.
Pilati C; Amessou M; Bihl MP; Balabaud C; Nhieu JT; Paradis V; Nault JC; Izard T; Bioulac-Sage P; Couchy G; Poussin K; Zucman-Rossi J
J Exp Med; 2011 Jul; 208(7):1359-66. PubMed ID: 21690253
[TBL] [Abstract][Full Text] [Related]
14. Selective loss of function variants in
Shahin T; Aschenbrenner D; Cagdas D; Bal SK; Conde CD; Garncarz W; Medgyesi D; Schwerd T; Karaatmaca B; Cetinkaya PG; Esenboga S; Twigg SRF; Cant A; Wilkie AOM; Tezcan I; Uhlig HH; Boztug K
Haematologica; 2019 Mar; 104(3):609-621. PubMed ID: 30309848
[TBL] [Abstract][Full Text] [Related]
15. Low incidence of IL6ST (gp130) mutations in exon 6 in lung cancer of a Chinese cohort.
Sun L; Sui L; Cong X; Ma K; Ma X; Huang Y; Fan C; Fu X; Ma K
Cancer Genet; 2014; 207(7-8):291-8. PubMed ID: 25242236
[TBL] [Abstract][Full Text] [Related]
16. Silibinin eliminates mitochondrial ROS and restores autophagy through IL6ST/JAK2/STAT3 signaling pathway to protect cardiomyocytes from doxorubicin-induced injury.
Li W; Qu X; Kang X; Zhang H; Zhang X; Hu H; Yao L; Zhang L; Zheng J; Zheng Y; Zhang J; Xu Y
Eur J Pharmacol; 2022 Aug; 929():175153. PubMed ID: 35839932
[TBL] [Abstract][Full Text] [Related]
17. Absence of GP130 cytokine receptor signaling causes extended Stüve-Wiedemann syndrome.
Chen YH; Grigelioniene G; Newton PT; Gullander J; Elfving M; Hammarsjö A; Batkovskyte D; Alsaif HS; Kurdi WIY; Abdulwahab F; Shanmugasundaram V; Devey L; Bacrot S; Brodszki J; Huber C; Hamel B; Gisselsson D; Papadogiannakis N; Jedrycha K; Gürtl-Lackner B; Chagin AS; Nishimura G; Aschenbrenner D; Alkuraya FS; Laurence A; Cormier-Daire V; Uhlig HH
J Exp Med; 2020 Mar; 217(3):. PubMed ID: 31914175
[TBL] [Abstract][Full Text] [Related]
18. Tofacitinib ameliorates inflammation in a rat model of airway neutrophilia induced by inhaled LPS.
Calama E; Ramis I; Domènech A; Carreño C; De Alba J; Prats N; Miralpeix M
Pulm Pharmacol Ther; 2017 Apr; 43():60-67. PubMed ID: 28087469
[TBL] [Abstract][Full Text] [Related]
19. Complex Autoinflammatory Syndrome Unveils Fundamental Principles of JAK1 Kinase Transcriptional and Biochemical Function.
Gruber CN; Calis JJA; Buta S; Evrony G; Martin JC; Uhl SA; Caron R; Jarchin L; Dunkin D; Phelps R; Webb BD; Saland JM; Merad M; Orange JS; Mace EM; Rosenberg BR; Gelb BD; Bogunovic D
Immunity; 2020 Sep; 53(3):672-684.e11. PubMed ID: 32750333
[TBL] [Abstract][Full Text] [Related]
20. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
